Research and Clinical Trials
A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]
The percentage of women who are screened for cervical cancer may actually be far lower than national statistics suggest they are, according to a Mayo[...]
A study led by Mayo Clinic researchers Zhi Zhang Yang, M.D., and Stephen M. Ansell, M.D., Ph.D., has found that healthy white blood cells called[...]
Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]
As I write this message, the snow has finally stopped in Minnesota and the month of May is upon us — a time each year[...]
Mayo Clinic researchers have found that the oral drug apixaban is safe and effective to treat blood clots in patients undergoing cancer therapy. Apixaban was[...]
A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]
Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.
Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction with the drug memantine better preserved cognitive function and demonstrated[...]